• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE VANTAGE WITH SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE VANTAGE WITH SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number PED3-027-500-14
Device Problems Positioning Failure (1158); Unintended Movement (3026); Physical Resistance/Sticking (4012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/24/2022
Event Type  malfunction  
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that a ped3 pipeline vantage had difficult placement and was not able to be resheathed.A ped2 pipeline shield was used and would not open distally.While deploying the ped3 pipeline vantage, to reposition and adjust, the healthcare provider (hcp) tried to resheath it, but the device got stiff and it did not allow him to resheath.It was reported as movement during placement.Only one pipeline was being used.There was severe friction or difficulty during delivery and positioning.The ped3 was implanted at the intended location.The ped3 missed the landing zone.A snare/retrieval device was used.The device did not jump during deployment.The ped3 was placed at least 3mm past the aneurysm neck on each side.No side branches were covered by the pipeline.The tip of the catheter did not move during deployment.  the hcp tried to use ped2 pipeline shield in the same patient after the failure of ped3 pipeline vantage, but it did not open distally even after multiple tries.It was not positioned in a bend.More than 50% had been deployed when it failed to open.The pipeline was resheathed less than or equal to 2 times.No additional steps were required to open the pipeline.The ped2 was removed from the patient with the microcatheter.The devices were used for an indication that was not approved.They were used on a wide neck aneurysm.The devices were prepared as indicated in the instructions for use (ifu).Doctor used a different flow diverter from the other manufacturer and it was successfully deployed.The patient was being treated for an unruptured, amorphous aneurysm.The distal landing "zine" was 3.7mm and the proximal lainding "zine" was 4.61mm. while deploying the ped3 pipeline vantage, to reposition and adjust, the healthcare provider (hcp) tried to resheath it, but the device got stiff and it did not allow him to resheath.Only one pipeline was being used.There was severe friction or difficulty during delivery and positioning.The ped3 was implanted at the intended location.The ped3 missed the landing zone.A snare/retrieval device was used.The device did not jump during deployment.The ped3 was placed at least 3mm past the aneurysm neck on each side.No side branches were covered by the pipeline.The tip of the catheter did not move during deployment.  the hcp tried to use ped2 pipeline shield in the same patient after the failure of ped3 pipeline vantage but it did not open distally even after multiple tries.It was not positioned in a bend.More than 50% had been deployed when it failed to open.The pipeline was resheathed less than or equal to 2 times.No additional steps were required to open the pipeline.The ped2 was removed from the patient with the microcatheter.The devices were used for an indication that was not approved.They were used on a wide neck aneurysm.The devices were  doctor used a different flow diverter from the other manufacturer and it was successfully deployed.Vessel tortuosity was moderate.Ancillary devices: sheath, phenom plus guide catheter, phenom 27 microcatheter, guidewire.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE VANTAGE WITH SHIELD TECHNOLOGY
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key14557860
MDR Text Key300800409
Report Number2029214-2022-00913
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/01/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPED3-027-500-14
Device Catalogue NumberPED3-027-500-14
Device Lot NumberB273761
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/24/2022
Date Device Manufactured09/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-